Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
O Abla, E Jacobsen, J Picarsic… - Blood, The Journal …, 2018 - ashpublications.org
Abstract Rosai-Dorfman-Destombes disease (RDD) is a rare non–Langerhans cell
histiocytosis characterized by accumulation of activated histiocytes within affected tissues …
histiocytosis characterized by accumulation of activated histiocytes within affected tissues …
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era
Erdheim-Chester disease (ECD) is a rare histiocytosis that was recently recognized as a
neoplastic disorder owing to the discovery of recurrent activating MAPK (RAS-RAF-MEK …
neoplastic disorder owing to the discovery of recurrent activating MAPK (RAS-RAF-MEK …
Histiocytosis
Histiocytoses constitute a heterogeneous group of rare disorders, characterised by
infiltration of almost any organ by myeloid cells with diverse macrophage or dendritic cell …
infiltration of almost any organ by myeloid cells with diverse macrophage or dendritic cell …
The clinical spectrum of Erdheim-Chester disease: an observational cohort study
JI Estrada-Veras, KJ O'Brien, LC Boyd… - Blood …, 2017 - ashpublications.org
Erdheim-Chester disease (ECD) is a rare, potentially fatal multiorgan myeloid neoplasm
occurring mainly in adults. The diagnosis is established by clinical, radiologic, and histologic …
occurring mainly in adults. The diagnosis is established by clinical, radiologic, and histologic …
Histiocytoses: emerging neoplasia behind inflammation
J Haroche, F Cohen-Aubart, BJ Rollins… - The Lancet …, 2017 - thelancet.com
Histiocytoses are disorders characterised by inflammation and the accumulation of cells
derived from the monocyte and macrophage lineages, which results in tissue damage …
derived from the monocyte and macrophage lineages, which results in tissue damage …
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial
Y Ji, S Chen, J Zhou, K Yang, X Zhang… - Blood, The Journal …, 2022 - ashpublications.org
Abstract The Kasabach-Merritt phenomenon (KMP) in kaposiform hemangioendothelioma
(KHE) is characterized by life-threatening thrombocytopenia and consumptive coagulopathy …
(KHE) is characterized by life-threatening thrombocytopenia and consumptive coagulopathy …
Erdheim-chester disease
J Haroche, F Cohen-Aubart… - Blood, The Journal of the …, 2020 - ashpublications.org
Erdheim-Chester disease (ECD) is characterized by the infiltration of tissues by foamy
CD68+ CD1a− histiocytes, with 1500 known cases since 1930. Mutations activating the …
CD68+ CD1a− histiocytes, with 1500 known cases since 1930. Mutations activating the …
Histiocytic neoplasms, version 2.2021, NCCN clinical practice guidelines in oncology
RS Go, E Jacobsen, R Baiocchi, I Buhtoiarov… - Journal of the National …, 2021 - jnccn.org
Histiocytic neoplasms are rare hematologic disorders accounting for less than 1% of cancers
of the soft tissue and lymph nodes. Clinical presentation and prognosis of these disorders …
of the soft tissue and lymph nodes. Clinical presentation and prognosis of these disorders …
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis
Erdheim-Chester disease (ECD) and Rosai-Dorfman disease (RDD) are rare non-
Langerhans cell histiocytoses (non-LCHs), for which therapeutic options are limited. MAPK …
Langerhans cell histiocytoses (non-LCHs), for which therapeutic options are limited. MAPK …
Erdheim–Chester disease: a rapidly evolving disease model
Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis with a putative
neoplastic and inflammatory nature. The disease is driven by mutations in proto-oncogenes …
neoplastic and inflammatory nature. The disease is driven by mutations in proto-oncogenes …